High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis.
about
CD74 in Kidney DiseaseFusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates.Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.Decreased frequencies of circulating follicular helper T cell counterparts and plasmablasts in ankylosing spondylitis patients Naïve for TNF blockers.Update on ankylosing spondylitis: current concepts in pathogenesis.Advances in classification, basic mechanisms and clinical science in ankylosing spondylitis and axial spondyloarthritis.The ASAS Criteria for Axial Spondyloarthritis: Strengths, Weaknesses, and Proposals for a Way Forward.New insights toward the pathogenesis of ankylosing spondylitis; genetic variations and epigenetic modifications.Autoinflammation and HLA-B27: Beyond Antigen Presentation.Lessons to be learned from serum biomarkers in psoriasis and IBD - the potential role in SpA.Causes and consequences of endoplasmic reticulum stress in rheumatic disease.Macrophage Migration Inhibitory Factor Induces Inflammation and Predicts Spinal Progression in Ankylosing Spondylitis.An update on biomarker discovery and use in axial spondyloarthritis.Unmet Needs in Axial Spondyloarthritis.Anti-CD74 antibodies have no diagnostic value in early axial spondyloarthritis: data from the spondyloarthritis caught early (SPACE) cohort.Axial spondyloarthritis.[New biomarkers for large vessel vasculitis and spondyloarthropathies].Development of a Molecular Adjuvant to Enhance Antigen-Specific CD8 T Cell Responses
P2860
Q26781254-AACD6C7E-AE4C-49EB-97FF-AEDC43D35E1FQ33586992-1D669E2B-177E-4F80-9AE0-496ED94FC6A1Q33779750-ADB09B50-D3C7-4E30-A1EE-422ED8B63904Q34156020-E467B31E-9FE1-4F5A-A135-35BDF09C7A63Q34450732-C9441069-E139-4C78-88A7-9AF4029DA65EQ38240821-98A67986-12F6-46BB-A124-9D319A79309CQ38569186-0860A486-2A95-4FDC-9658-F10D6699D2E7Q38840984-545DEF02-511A-4F5F-9D2C-54CA7482650BQ38845301-43FBA493-732B-4398-821A-3A053E499B20Q38972679-FE06B217-0CD1-495F-9718-1CD9C4948C31Q39025066-FD885587-2000-4D31-A99A-5A8EB7654DE2Q46274917-7724EA5C-3A77-4F75-8F36-1DB694387F62Q47787817-8873E9CC-FB3E-4BA7-89AA-D367A0EC36A3Q48287506-802AD764-A126-4E2B-9083-A631876BF163Q52680961-F428ABB8-AD1D-4447-8730-19274EE83928Q52870848-51710CE3-E285-4FD0-A30A-ADDA6522C5BEQ53280164-D17C438F-546B-4DE4-8E5A-ECD822B8C813Q57292428-ABDF2CC5-B3D6-42A0-860E-F1A27629EBB5
P2860
High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
High prevalence of anti-CD74 a ...... with axial spondyloarthritis.
@en
High prevalence of anti-CD74 a ...... ciated invariant chain peptide
@nl
type
label
High prevalence of anti-CD74 a ...... with axial spondyloarthritis.
@en
High prevalence of anti-CD74 a ...... ciated invariant chain peptide
@nl
prefLabel
High prevalence of anti-CD74 a ...... with axial spondyloarthritis.
@en
High prevalence of anti-CD74 a ...... ciated invariant chain peptide
@nl
P2093
P2860
P1476
High prevalence of anti-CD74 a ...... with axial spondyloarthritis.
@en
P2093
P2860
P304
P356
10.1136/ANNRHEUMDIS-2012-202177
P407
P577
2013-05-03T00:00:00Z